Mechanical Disruption of the Inner Limiting Membrane In Vivo Enhances Targeting to the Inner Retina.

"Disclosure: J.L. Do, Auxilium Biotechnologies (C), Nicox (C), VoxelCloud (C); N. Pedroarena-Leal, None; M. Louie, None; P. Avila Garcia, None; A. Alnihmy, None; A. Patel, None; R.N. Weinreb, Abbvie (C), Alcon (C), Allergan (C), Amydis (C), Centervue (R), Editas (C), Eyenovia (C), Heidelberg Engineering (R), Iantrek (C), Implandata (C), IOPtic (C), Konan (R), Nicox (C), Optovue (R), Santen (C), Topcon (C), Toromedes (F, P), Zeiss (P, R), Zilia (R); K.J. Wahlin, None; A. La Torre Vila, None; D.S. Welsbie, Perceive Biotherapeutics (C, F)"

"Supported in part by a National Eye Institute, National Institutes of Health, K12 Career Development grant (5K12EY024225), K08 Career Development grant (K08EY033032), and P30 core grant (P30EY022589); by an American Glaucoma Society Young Clinician Scientist Grant; by a Physician Scientist Award from Research to Prevent Blindness; by a Catalyst for a Cure Award from the Glaucoma Research Foundation; by an unrestricted grant from Research to Prevent Blindness; and by the Hanna and Mark Gleiberman Center for Glaucoma Research (La Jolla, CA)."